上海鹍远生物技术有限公司 Shanghai Far Biological Technology Co. LTD
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Singlera Genomics Receives FDA Breakthrough Device Designation for PDACatch, a Liquid Biopsy Assay for Pancreatic Cancer Detection in High-Risk Individuals 2023-05-08 22:00
Singlera Genomics announces research collaboration with Astellas Pharma pursuing methylation-based tools to better understand biological reactions to pharmaceuticals 2022-04-05 21:56
Singlera Genomics raises $150 million in Series B financing to promote the development and commercialization of early cancer screening products 2020-12-15 22:00
Singlera Genomics and Fudan University unveiled results demonstrating detection of five common cancers earlier than standard test 2020-07-21 23:00
Singlera Genomics Meets with FDA for Rapid Colon Cancer Assay and Has a Clear Path Forward 2020-05-12 01:39
Singlera Genomics ColonES test selected as finalist for AACC Disruptive Technology Award 2019-05-29 21:00
Singlera Genomics Raises $60 Million in Series A+ Financing 2018-03-27 21:30
Singlera Genomics Raises $20 Million In Series A Financing Led by Lilly Asia Ventures 2016-08-22 22:30
1